SGLT2 Inhibitors for HF: What Is the Effect of Empagliflozin on Cardiovascular and Renal Events in HFrEF Based on the EMPEROR-Reduced Trial?

149 views
March 30, 2021
0 Comments
Login to view comments. Click here to Login